fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Listed in the December 27, 2023 extract; not in the current extract (September 22, 2026): Minitran (02163527), Minitran (02163535). Source: odb-formulary-ed43-extract-2023-12-27.xml; compared with odb-formulary-ed43-extract-2026-09-22.xml.

Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.

Nitroglycerin

Form:

20 of 20 products shown

13 general benefit · 5 not a benefit · 2 listing conditions apply

Nitrostat · DIN 00037613 · 0.3 mg · SL tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
No interchangeable product listed in the Ontario extract
Nitrostat · DIN 00037613 Manufacturer: Upjohn Canada ULC; listing date 1996-10-01 Health Canada: Marketed since 2023-08-03 · brand NITROSTAT · ATC C01DA02 GLYCERYL TRINITRATE · form Tablet · route Sublingual · ingredients NITROGLYCERIN 0.3 MG · company Bgp pharma ulc · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Nitrostat: Formulary list price $0.19 per unit (the source does not state the unit; exact figure $0.1888). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00037613)

Source record
DIN 00037613: Nitrostat Raw flags: sec3=Y Item: 241200004; group id 369; item number 0864; lccId None; manufacturer id UJC Source form: SL Tab; strength: 0.3mg Recorded listing: General benefit Source prices (unrounded): $0.1888; ministry $0.1888 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00037613 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1254
Shortage status: resolved shortage (ended May 29, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00037613
Shortage record checked October 6, 2026

Trinipatch 0.4 · DIN 02230733 · 0.4 mg/Hr/14 Sq Cm · Patch

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
No interchangeable product listed in the Ontario extract
Trinipatch 0.4 · DIN 02230733 Manufacturer: Knight Therapeutics Inc.; listing date 1999-04-15 Health Canada: Marketed since 2026-02-02 · brand TRINIPATCH 0.4 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch · route Transdermal · ingredients NITROGLYCERIN 0.4 MG/HOUR · company Knight therapeutics inc. · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Trinipatch 0.4: Formulary list price $0.90 per unit (the source does not state the unit; exact figure $0.8950). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02230733)

Source record
DIN 02230733: Trinipatch 0.4 Raw flags: sec3=Y Item: 241200067; group id 369; item number 0862; lccId None; manufacturer id KNT Source form: Patch; strength: 0.4mg/Hr/14 Sq Cm Recorded listing: General benefit Source prices (unrounded): $0.8950; ministry $0.8950 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02230733 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=49995
Shortage status: resolved shortage (ended February 7, 2024); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02230733
Shortage record checked October 6, 2026

Nitrolingual Pump Spray · DIN 02231441 · 0.4 mg/Metered Dose · Spray-200 Dose Pk

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Nitrolingual Pump Spray · DIN 02231441 Manufacturer: Sanofi Aventis Pharma; listing date 1999-04-15 Health Canada: Marketed since 2026-07-16 · brand NITROLINGUAL PUMPSPRAY · ATC C01DA02 GLYCERYL TRINITRATE · form Metered-dose pump · route Sublingual · ingredients NITROGLYCERIN 0.4 MG/ACT · company G pohl-boskamp gmbh & co kg · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02231441)

Source record
DIN 02231441: Nitrolingual Pump Spray Raw flags: sec3=Y Item: 241200069; group id 369; item number 0869; lccId None; manufacturer id SAV Source form: Spray-200 Dose Pk; strength: 0.4mg/Metered Dose Recorded listing: General benefit Source prices (unrounded): $16.0000; ministry $8.4200 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02231441 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50758
Interchangeable products
Rho-Nitro Pumpspray · DIN 02238998 · $8.4200
Shortage status: resolved shortage (ended June 14, 2024); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02231441
Shortage record checked October 6, 2026

Rho-Nitro Pumpspray · DIN 02238998 · 0.4 mg/Metered Dose · Spray-200 Dose Pk

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Rho-Nitro Pumpspray · DIN 02238998 Manufacturer: Sandoz Canada Inc.; listing date 2014-06-26 Health Canada: Marketed since 2011-02-26 · brand RHO-NITRO PUMPSPRAY · ATC C01DA02 GLYCERYL TRINITRATE · form Metered-dose pump · route Sublingual · ingredients NITROGLYCERIN 0.4 MG/ACT · company Sandoz canada incorporated · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Rho-Nitro Pumpspray: Formulary list price $8.42 per unit (the source does not state the unit; exact figure $8.4200). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02238998)

Source record
DIN 02238998: Rho-Nitro Pumpspray Raw flags: sec3=Y Item: 241200069; group id 369; item number 0869; lccId None; manufacturer id SDZ Source form: Spray-200 Dose Pk; strength: 0.4mg/Metered Dose Recorded listing: General benefit Source prices (unrounded): $8.4200; ministry $8.4200 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02238998 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=62447
Interchangeable products
Nitrolingual Pump Spray · DIN 02231441 · $8.4200
Shortage status: To be discontinued; reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02238998
Shortage record checked October 6, 2026

Mylan-Nitro 0.4 · DIN 02407450 · 0.4 mg/Hr · Transdermal Patch

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Mylan-Nitro 0.4 · DIN 02407450 Manufacturer: Mylan Pharmaceuticals ULC; listing date 2013-11-28 Health Canada: Marketed since 2013-06-04 · brand MYLAN-NITRO PATCH 0.4 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.4 MG/HOUR · company Mylan pharmaceuticals ulc · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Mylan-Nitro 0.4: Formulary list price $0.50 per unit (the source does not state the unit; exact figure $0.5040). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02407450)

Source record
DIN 02407450: Mylan-Nitro 0.4 Raw flags: sec3=Y Item: 241200071; group id 369; item number 0871; lccId None; manufacturer id MYL Source form: Transdermal Patch; strength: 0.4mg/Hr Recorded listing: General benefit Source prices (unrounded): $0.5040; ministry $0.5040 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02407450 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89214
Interchangeable products
Nitro-Dur · DIN 01911902 · $0.5040
Shortage status: resolved shortage (ended August 14, 2017); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02407450
Shortage record checked October 6, 2026

Nitro-Dur · DIN 01911902 · 0.4 mg/Hr · Transdermal Patch

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Nitro-Dur · DIN 01911902 Manufacturer: Dr. Reddy's Laboratories Inc.; listing date 1996-10-01 Health Canada: Marketed since 2018-07-12 · brand NITRO-DUR 0.4 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.4 MG/HOUR · company Uspharma ltd · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Nitro-Dur: Formulary list price $0.50 per unit (the source does not state the unit; exact figure $0.5040). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01911902)

Source record
DIN 01911902: Nitro-Dur Raw flags: sec3=Y Item: 241200071; group id 369; item number 0871; lccId None; manufacturer id DRR Source form: Transdermal Patch; strength: 0.4mg/Hr Recorded listing: General benefit Source prices (unrounded): $0.5040; ministry $0.5040 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01911902 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=11225
Interchangeable products
Mylan-Nitro 0.4 · DIN 02407450 · $0.5040
Shortage status: resolved shortage (ended February 10, 2023); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01911902
Shortage record checked October 6, 2026

Trinipatch 0.6 · DIN 02230734 · 0.6 mg/Hr/21 Sq Cm · Patch

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
No interchangeable product listed in the Ontario extract
Trinipatch 0.6 · DIN 02230734 Manufacturer: Knight Therapeutics Inc.; listing date 1999-04-15 Health Canada: Marketed since 2026-02-03 · brand TRINIPATCH 0.6 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch · route Transdermal · ingredients NITROGLYCERIN 0.6 MG/HOUR · company Knight therapeutics inc. · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Trinipatch 0.6: Formulary list price $0.90 per unit (the source does not state the unit; exact figure $0.8950). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02230734)

Source record
DIN 02230734: Trinipatch 0.6 Raw flags: sec3=Y Item: 241200068; group id 369; item number 0863; lccId None; manufacturer id KNT Source form: Patch; strength: 0.6mg/Hr/21 Sq Cm Recorded listing: General benefit Source prices (unrounded): $0.8950; ministry $0.8950 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02230734 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=49996
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02230734
Shortage record checked October 6, 2026

Nitrostat · DIN 00037621 · 0.6 mg · SL tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
No interchangeable product listed in the Ontario extract
Nitrostat · DIN 00037621 Manufacturer: Upjohn Canada ULC; listing date 1996-10-01 Health Canada: Marketed since 2023-08-03 · brand NITROSTAT · ATC C01DA02 GLYCERYL TRINITRATE · form Tablet · route Sublingual · ingredients NITROGLYCERIN 0.6 MG · company Bgp pharma ulc · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Nitrostat: Formulary list price $0.19 per unit (the source does not state the unit; exact figure $0.1888). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00037621)

Source record
DIN 00037621: Nitrostat Raw flags: sec3=Y, selfMed=Y Item: 241200003; group id 369; item number 0865; lccId None; manufacturer id UJC Source form: SL Tab; strength: 0.6mg Recorded listing: General benefit; self-medication (OTC-type) product Source prices (unrounded): $0.1888; ministry $0.1888 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00037621 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=1253
Shortage status: active shortage (reported September 1, 2026, estimated to end October 20, 2026, last updated September 29, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00037621
Shortage record checked October 6, 2026

Mylan-Nitro 0.6 · DIN 02407469 · 0.6 mg/Hr · Transdermal Patch

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Mylan-Nitro 0.6 · DIN 02407469 Manufacturer: Mylan Pharmaceuticals ULC; listing date 2013-11-28 Health Canada: Marketed since 2013-06-04 · brand MYLAN-NITRO PATCH 0.6 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.6 MG/HOUR · company Mylan pharmaceuticals ulc · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Mylan-Nitro 0.6: Formulary list price $0.50 per unit (the source does not state the unit; exact figure $0.5040). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02407469)

Source record
DIN 02407469: Mylan-Nitro 0.6 Raw flags: sec3=Y Item: 241200072; group id 369; item number 0872; lccId None; manufacturer id MYL Source form: Transdermal Patch; strength: 0.6mg/Hr Recorded listing: General benefit Source prices (unrounded): $0.5040; ministry $0.5040 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02407469 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89215
Interchangeable products
Nitro-Dur · DIN 01911929 · $0.5040
Shortage status: avoided shortage; reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02407469
Shortage record checked October 6, 2026

Nitro-Dur · DIN 01911929 · 0.6 mg/Hr · Transdermal Patch

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Nitro-Dur · DIN 01911929 Manufacturer: Dr. Reddy's Laboratories Inc.; listing date 1996-10-01 Health Canada: Marketed since 2018-07-12 · brand NITRO-DUR 0.6 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.6 MG/HOUR · company Uspharma ltd · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Nitro-Dur: Formulary list price $0.50 per unit (the source does not state the unit; exact figure $0.5040). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01911929)

Source record
DIN 01911929: Nitro-Dur Raw flags: sec3=Y Item: 241200072; group id 369; item number 0872; lccId None; manufacturer id DRR Source form: Transdermal Patch; strength: 0.6mg/Hr Recorded listing: General benefit Source prices (unrounded): $0.5040; ministry $0.5040 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01911929 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=11226
Interchangeable products
Mylan-Nitro 0.6 · DIN 02407469 · $0.5040
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01911929
Shortage record checked October 6, 2026

Mylan-Nitro 0.2 · DIN 02407442 · 0.2 mg/Hr · Transdermal Patch

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives
Patient paysNot paid by ODB 65 and over; see alternatives
1 brand, same coverage
Mylan-Nitro 0.2 · DIN 02407442 Manufacturer: Mylan Pharmaceuticals ULC; listing date 2013-11-28 Health Canada: Marketed since 2013-06-04 · brand MYLAN-NITRO PATCH 0.2 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.2 MG/HOUR · company Mylan pharmaceuticals ulc · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02407442)

Source record
DIN 02407442: Mylan-Nitro 0.2 Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 241200033; group id 369; item number 0870; lccId None; manufacturer id MYL Source form: Transdermal Patch; strength: 0.2mg/Hr Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $0.4687; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02407442 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89213
Interchangeable products
Nitro-Dur 0.2 · DIN 01911910 · not recorded
Shortage status: resolved shortage (ended October 18, 2017); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02407442
Shortage record checked October 6, 2026

Nitro-Dur 0.2 · DIN 01911910 · 0.2 mg/Hr · Transdermal Patch

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives
Patient paysNot paid by ODB 65 and over; see alternatives
1 brand, same coverage
Nitro-Dur 0.2 · DIN 01911910 Manufacturer: Dr. Reddy's Laboratories Inc.; listing date 2013-11-28 Health Canada: Marketed since 2018-07-12 · brand NITRO-DUR 0.2 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.2 MG/HOUR · company Uspharma ltd · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Nitro-Dur 0.2: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01911910)

Source record
DIN 01911910: Nitro-Dur 0.2 Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 241200033; group id 369; item number 0870; lccId None; manufacturer id DRR Source form: Transdermal Patch; strength: 0.2mg/Hr Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01911910 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=11227
Interchangeable products
Mylan-Nitro 0.2 · DIN 02407442 · not recorded
Shortage status: resolved shortage (ended February 3, 2023); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01911910
Shortage record checked October 6, 2026

Mylan-Nitro 0.8 · DIN 02407477 · 0.8 mg/Hr · Transdermal Patch

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives
Patient paysNot paid by ODB 65 and over; see alternatives
1 brand, same coverage
Mylan-Nitro 0.8 · DIN 02407477 Manufacturer: Mylan Pharmaceuticals ULC; listing date 2013-11-28 Health Canada: Marketed since 2013-06-04 · brand MYLAN-NITRO PATCH 0.8 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.8 MG/HOUR · company Mylan pharmaceuticals ulc · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02407477)

Source record
DIN 02407477: Mylan-Nitro 0.8 Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 241200058; group id 369; item number 0873; lccId None; manufacturer id MYL Source form: Transdermal Patch; strength: 0.8mg/Hr Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $0.9559; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02407477 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89216
Interchangeable products
Nitro-Dur 0.8 · DIN 02011271 · not recorded
Shortage status: resolved shortage (ended June 7, 2017); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02407477
Shortage record checked October 6, 2026

Nitro-Dur 0.8 · DIN 02011271 · 0.8 mg/Hr · Transdermal Patch

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives
Patient paysNot paid by ODB 65 and over; see alternatives
1 brand, same coverage
Nitro-Dur 0.8 · DIN 02011271 Manufacturer: Dr. Reddy's Laboratories Inc.; listing date 2013-11-28 Health Canada: Marketed since 2018-07-12 · brand NITRO-DUR 0.8 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.8 MG/HOUR · company Uspharma ltd · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Nitro-Dur 0.8: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02011271)

Source record
DIN 02011271: Nitro-Dur 0.8 Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 241200058; group id 369; item number 0873; lccId None; manufacturer id DRR Source form: Transdermal Patch; strength: 0.8mg/Hr Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02011271 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=14742
Interchangeable products
Mylan-Nitro 0.8 · DIN 02407477 · not recorded
Shortage status: resolved shortage (ended February 3, 2023); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02011271
Shortage record checked October 6, 2026

Nitrolingual Pumpspray · PIN 09858317 · 0.4 mg/Metered Dose · Sp-180 Dose Pk

Temporary benefitOntario PIN; no Health Canada record under this code
StatusTemporary benefit
Write on scriptcheck temporary-benefit rules below
Patient paysNot paid by ODB 65 and over; see alternatives

No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN. Health Canada record for this brand: DIN 02231441 (Marketed, 2026-07-16) Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50758

Check Health Canada brand DIN
No interchangeable product listed in the Ontario extract
Nitrolingual Pumpspray · DIN 09858317 Manufacturer: Juno Pharmaceuticals Corp.; listing date 2023-11-30 No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN. Health Canada record for this brand: DIN 02231441 (Marketed, 2026-07-16) Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50758
Re-check Health Canada status and shortages (live)

Nitrolingual Pumpspray: Formulary list price $8.42 per unit (the source does not state the unit; exact figure $8.4200). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Ontario PIN; see Health Canada brand lookup · Verify on the e-Formulary ↗ (DIN 09858317)

Source record
DIN 09858317: Nitrolingual Pumpspray Raw flags: sec3c=Y Item: 241200111; group id 369; item number 0866; lccId None; manufacturer id JUN Source form: Sp-180 Dose Pk; strength: 0.4mg/Metered Dose Recorded listing: Temporary benefit (shortage substitute) Source prices (unrounded): $8.4200; ministry $8.4200 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=09858317 Health Canada record for this brand: DIN 02231441 (Marketed, July 16, 2026) Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50758
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=09858317
Shortage record checked October 6, 2026

Nitrolingual Pumpspray · PIN 09858327 · 0.4 mg/Metered Dose · Sp-75 Dose Pk

Temporary benefitOntario PIN; no Health Canada record under this code
StatusTemporary benefit
Write on scriptcheck temporary-benefit rules below
Patient paysNot paid by ODB 65 and over; see alternatives

No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN. Health Canada record for this brand: DIN 02231441 (Marketed, 2026-07-16) Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50758

Check Health Canada brand DIN
No interchangeable product listed in the Ontario extract
Nitrolingual Pumpspray · DIN 09858327 Manufacturer: Sanofi-Aventis Canada Inc.; listing date 2024-01-31 No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN. Health Canada record for this brand: DIN 02231441 (Marketed, 2026-07-16) Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50758
Re-check Health Canada status and shortages (live)

Nitrolingual Pumpspray: Formulary list price $9.40 per unit (the source does not state the unit; exact figure $9.4000). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Ontario PIN; see Health Canada brand lookup · Verify on the e-Formulary ↗ (DIN 09858327)

Source record
DIN 09858327: Nitrolingual Pumpspray Raw flags: sec3c=Y Item: 241200112; group id 369; item number 0867; lccId None; manufacturer id SAC Source form: Sp-75 Dose Pk; strength: 0.4mg/Metered Dose Recorded listing: Temporary benefit (shortage substitute) Source prices (unrounded): $9.4000; ministry $9.4000 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=09858327 Health Canada record for this brand: DIN 02231441 (Marketed, July 16, 2026) Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50758
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=09858327
Shortage record checked October 6, 2026

Transderm-Nitro · DIN 00852384 · 0.4 mg/Hr/20 Sq Cm · Patch

General benefit; Health Canada lists this DIN as Cancelled post market since 2022-04-05 — choose a marketed DIN from the same-category list.Discontinued April 5, 2022 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2022-04-05 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2022-04-05 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
No interchangeable product listed in the Ontario extract
Transderm-Nitro · DIN 00852384 Manufacturer: Novartis Pharma Canada Inc.; listing date 1996-12-19 Health Canada: Cancelled post market since 2022-04-05 · brand TRANSDERM-NITRO 0.4 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.4 MG/HOUR · company Novartis pharmaceuticals canada inc · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Transderm-Nitro: Formulary list price $1.00 per unit (the source does not state the unit; exact figure $1.0010). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00852384)

Source record
DIN 00852384: Transderm-Nitro Raw flags: sec3=Y Item: 241200034; group id 369; item number 0860; lccId None; manufacturer id NOV Source form: Patch; strength: 0.4mg/Hr/20 Sq Cm Recorded listing: General benefit Source prices (unrounded): $1.0010; ministry $1.0010 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00852384 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10116
Shortage status: discontinued (October 31, 2020, reported by NOVARTIS PHARMACEUTICALS CANADA INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00852384
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since April 5, 2022 — choose a marketed DIN from the same-category list.

Mylan-Nitro Sublingual Spray · DIN 02243588 · 0.4 mg/Metered Dose · Spray-200 Dose Pk

General benefit; Health Canada lists this DIN as Cancelled post market since 2024-05-01 — choose a marketed DIN from the same-category list.Discontinued May 1, 2024 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2024-05-01 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2024-05-01 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Mylan-Nitro Sublingual Spray · DIN 02243588 Manufacturer: Mylan Pharmaceuticals ULC; listing date 2003-01-30 Health Canada: Cancelled post market since 2024-05-01 · brand MYLAN-NITRO SUBLINGUAL SPRAY · ATC C01DA02 GLYCERYL TRINITRATE · form Metered-dose aerosol · route Sublingual · ingredients NITROGLYCERIN 0.4 MG/ACT · company Mylan pharmaceuticals ulc · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Mylan-Nitro Sublingual Spray: Formulary list price $8.46 per unit (the source does not state the unit; exact figure $8.4600). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02243588)

Source record
DIN 02243588: Mylan-Nitro Sublingual Spray Raw flags: sec3=Y Item: 241200017; group id 369; item number 0868; lccId None; manufacturer id MYL Source form: Spray-200 Dose Pk; strength: 0.4mg/Metered Dose Recorded listing: General benefit Source prices (unrounded): $8.4600; ministry $8.4600 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02243588 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=67506
Interchangeable products
Nitrolingual · DIN 01926721 · not recorded
Shortage status: discontinued (May 1, 2024, reported by MYLAN PHARMACEUTICALS ULC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02243588
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since May 1, 2024 — choose a marketed DIN from the same-category list.

Transderm-Nitro · DIN 02046156 · 0.6 mg/Hr/30 Sq Cm · Patch

General benefit; Health Canada lists this DIN as Cancelled post market since 2022-04-05 — choose a marketed DIN from the same-category list.Discontinued April 5, 2022 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2022-04-05 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2022-04-05 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
No interchangeable product listed in the Ontario extract
Transderm-Nitro · DIN 02046156 Manufacturer: Novartis Pharma Canada Inc.; listing date 1997-04-10 Health Canada: Cancelled post market since 2022-04-05 · brand TRANSDERM-NITRO 0.6 · ATC C01DA02 GLYCERYL TRINITRATE · form Patch (extended-release) · route Transdermal · ingredients NITROGLYCERIN 0.6 MG/HOUR · company Novartis pharmaceuticals canada inc · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Transderm-Nitro: Formulary list price $1.03 per unit (the source does not state the unit; exact figure $1.0290). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02046156)

Source record
DIN 02046156: Transderm-Nitro Raw flags: sec3=Y Item: 241200059; group id 369; item number 0861; lccId None; manufacturer id NOV Source form: Patch; strength: 0.6mg/Hr/30 Sq Cm Recorded listing: General benefit Source prices (unrounded): $1.0290; ministry $1.0290 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02046156 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=15572
Shortage status: discontinued (September 2, 2021, reported by NOVARTIS PHARMACEUTICALS CANADA INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02046156
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since April 5, 2022 — choose a marketed DIN from the same-category list.

Nitrolingual · DIN 01926721 · 0.4 mg/Metered Dose · Spray-200 Dose Pk

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2001-07-20 — choose a marketed DIN from the same-category list.Discontinued July 20, 2001 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2001-07-20 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2001-07-20 — choose a marketed DIN from the same-category list.
Patient paysNot paid by ODB 65 and over; see alternatives
1 brand, same coverage
Nitrolingual · DIN 01926721 Manufacturer: Aventis Pharma; listing date 1996-10-01 Health Canada: Cancelled post market since 2001-07-20 · brand NITROLINGUAL SPRAY 0.4MG/EAM · ATC C01DA02 GLYCERYL TRINITRATE · form Metered-dose aerosol · route Sublingual · ingredients NITROGLYCERIN 0.4 MG/ACT · company Aventis pharma inc · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Nitrolingual: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01926721)

Source record
DIN 01926721: Nitrolingual Raw flags: notABenefit=Y, sec3=Y Item: 241200017; group id 369; item number 0868; lccId None; manufacturer id AVE Source form: Spray-200 Dose Pk; strength: 0.4mg/Metered Dose Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01926721 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13160
Interchangeable products
Mylan-Nitro Sublingual Spray · DIN 02243588 · $8.4600
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01926721
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since July 20, 2001 — choose a marketed DIN from the same-category list.

Other products in the same Health Canada class (C01D, C01DA): coverage varies; not interchangeable

  • Isosorbide dinitrate (Isdn): general benefit, not a benefit
  • Isosorbide + mononitrate (Imdur): not a benefit
  • Vericiguat (Verquvo): limited Use 685
Other drugs in the same formulary class (24:12 Vasodilating Drugs) and how they are covered

Matched class: 24:12 Vasodilating Drugs

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Public program routes: ODB 65 and over Some products covered without a code (check the product listing): ISOSORBIDE DINITRATE 24:12 Vasodilating Drugs

ISOSORBIDE DINITRATE

· 6 products · General benefit (3), Listed, not a benefit (3) · strengths: 5mg, 10mg, 30mg · SL Tab, Tab

ISOSORBIDE-5-MONONITRATE

· 3 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 60mg · ER Tab

VERICIGUAT

· 3 products · Limited Use, codes 685 · strengths: 2.5mg, 5mg, 10mg · Tab

DIPYRIDAMOLE & ACETYLSALICYLIC ACID

· 2 products · Listed, not a benefit (1), Limited Use, codes 349 (1) · strengths: 200mg/25mg · Cap

NIMODIPINE

· 1 products · Limited Use, codes 42, 43 · strengths: 30mg · Tab

AMBRISENTAN

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 5mg, 10mg · Tab

BETAHISTINE DIHYDROCHLORIDE

· 24 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 8mg, 16mg, 24mg · Tab

BOSENTAN MONOHYDRATE

· 14 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 62.5mg, 125mg · Tab

DIPYRIDAMOLE

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 25mg, 50mg, 75mg · Tab

RIOCIGUAT

· 10 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 0.5mg, 1.5mg, 1mg, 2.5mg, 2mg · Tab

TADALAFIL

· 73 products · Off-Formulary Interchangeable, not an ODB benefit (72), Off-Formulary Interchangeable, not an ODB benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (1) · strengths: 2.5mg, 5mg, 10mg, 20mg · Tab

VARDENAFIL HCL

· 16 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 10mg, 5mg, 20mg · Orally Disintergrating Tab, Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 24:12
Full class listing Related classes: 24:04 Cardiac Drugs, 24:06 Antilipemic Drugs, 24:08 Hypotensive Drugs (For Diuretics See 40:28), 24:32 Renin-Angiotensin Aldosterone Inhibitors Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE NITROSTAT (nitroglycerin sublingual tablets) are indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease. https://pdf.hres.ca/dpd_pm/00070110.PDF PM date: March 27, 2023 Source product: NITROSTAT; DIN 00037613; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Rho-Nitro Pumpspray · DIN 02238998 Shortage status: To be discontinued; reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02238998

Check this DIN again

Nitrostat · DIN 00037621 Shortage status: active shortage (reported 2026-09-01, estimated to end 2026-10-20, last updated 2026-09-29); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00037621

Check this DIN again

Transderm-Nitro · DIN 00852384 Shortage status: discontinued (2020-10-31, reported by NOVARTIS PHARMACEUTICALS CANADA INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00852384

Check this DIN again

Mylan-Nitro Sublingual Spray · DIN 02243588 Shortage status: discontinued (2024-05-01, reported by MYLAN PHARMACEUTICALS ULC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02243588

Check this DIN again

Transderm-Nitro · DIN 02046156 Shortage status: discontinued (2021-09-02, reported by NOVARTIS PHARMACEUTICALS CANADA INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02046156

Check this DIN again
Program rules and quotes
Public program routes (Ontario context; residency, health-card/OHIP requirements and enrolment must be confirmed from the quoted rules): ODB 65 and over (seniors path) Eligibility: You may qualify for the Ontario Drug Benefit (ODB) program when you turn 65 years old. (ontario.ca, August 18, 2026 ↗) Eligibility: The Ontario Drug Benefit program is for Ontario residents only and prescriptions must be filled in an Ontario pharmacy to be covered. (ontario.ca, August 18, 2026 ↗) Eligibility: Individual annual net income threshold Program year August 1, 2026 to July 31, 2027: $25,480 This applies to a senior who: does not have a spouse has a married spouse with whom they no longer live in a conjugal relationship has a spouse living in a long-term care home or community home for opportunity (ontario.ca, July 2, 2026 ↗) Eligibility: Combined annual net income requirement Program year August 1, 2026 to July 31, 2027: $42,290 This applies to a senior who has a spouse, other than a spouse described. (ontario.ca, July 2, 2026 ↗) Eligibility: See the first-year deductible table. (ontario.ca, August 18, 2026 ↗) What it pays / costs: the first $100 of total prescription costs each program year (August 1 to July 31 the following year) (ontario.ca, August 18, 2026 ↗) What it pays / costs: up to $6.11 for each prescription filled or refilled (after paying the deductible) (ontario.ca, August 18, 2026 ↗) What it pays / costs: Seniors enrolled in the Seniors Co-Payment Program have no annual deductible and a reduced co-payment of up to $2. (ontario.ca, August 18, 2026 ↗) Enrolment: "We will send you a letter about 3 months before your 65th birthday to let you know you will automatically join the Ontario Drug Benefit program on the first day of the month after you turn 65 years old." (ontario.ca, August 18, 2026 ↗) Enrolment: "To enroll in the Seniors Co-Payment Program, a senior must submit an application to that program and qualify under certain income eligibility thresholds." (ontario.ca, August 18, 2026 ↗)
First year on ODB? The deductible depends on birth month
For your first year of Ontario Drug Benefit program eligibility, depending on the month you turn 65, the deductible may be lower than $100. That’s because the amount of the deductible is based on the number of months between your official start date (the first day of the month after you turn 65) and July 31 (the last day of the Ontario Drug Benefit program year). For example, if you turned 65 on April 15, your official start date would be May 1. Counting from May 1 to July 31 your deductible for the first year would be $25. Use this chart below to see what the deductible will be in your first year:
Month you were bornAmount of first-year deductible
July$100.00
August$91.67
September$83.33
October$75.00
November$66.67
December$58.33
January$50.00
February$41.67
March$33.33
April$25.00
May$16.67
June$8.33

Ontario source · 2026-08-18

Other review policies

For Mylan-Nitro 0.2, Nitro-Dur 0.2, Mylan-Nitro 0.8, Nitro-Dur 0.8, Nitrolingual: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.

For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy

Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.

Ontario source; updated September 15, 2026

For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)

Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.

Ontario source; updated September 15, 2026